<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Allegra A. Petti et al.|New England Journal of Medicine|2016Cited by 783
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Gregory A. Abel, Daniel J. DeAngelo et al.|Blood Advances|2021Cited by 38